(Q22242637)

2

A M

Diehl

1 reference

8 February 2023

M. Wiseman

3

M

Wiseman

1 reference

8 February 2023

G. H. Farr

4

G H Jr

Farr

1 reference

8 February 2023

R. P. Perrillo

5

R P

Alimentary Pharmacology & Therapeutics

Perrillo

1 reference

8 February 2023

language of work or name

English

0 references

publication date

July 2004

0 references

published in

0 references

volume

20

0 references

page(s)

23-28

0 references

issue

1

0 references

cites work

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02025.X

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02025.X

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02025.X

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02025.X

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02025.X

Nonalcoholic fatty liver disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Nonalcoholic Steatohepatitis

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

21 January 2018

Mallory bodies revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Repeatability characteristics of simple indices of insulin resistance: implications for research applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Nonalcoholic steatohepatitis: an expanded clinical entity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Steatohepatitis: a tale of two "hits"?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02025.X

7 January 2021

10.1111/J.1365-2036.2004.02025.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4356520

OpenCitations bibliographic resource ID

4356520

1 reference